Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
A Hakim, B Guido, L Narsineni, DW Chen… - Advanced drug delivery …, 2023 - Elsevier
Glaucoma is the result of the gradual death of retinal ganglion cells (RGCs) whose axons
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems.
A Hakim, B Guido, L Narsineni, DW Chen… - … Drug Delivery Reviews, 2023 - europepmc.org
Glaucoma is the result of the gradual death of retinal ganglion cells (RGCs) whose axons
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factors …
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factors …
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
A Hakim, B Guido, L Narsineni… - Advanced drug …, 2023 - pubmed.ncbi.nlm.nih.gov
Glaucoma is the result of the gradual death of retinal ganglion cells (RGCs) whose axons
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …